Evidence map›Paper›PMID 39940972›Full record

ArticleInternational journal of molecular sciences2025

P2Y

Reece A Sophocleous, Stephen J Curtis, Belinda L Curtis, Lezanne Ooi, Ronald Sluyter

Abstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Advances in nucleotide-based P2Y₁ antagonism: implications for cardiovascular therapeutics.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Reece A SophocleousMolecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.ORCID 0000-0002-8339-9090
Stephen J CurtisYour Village Vet Balgownie, Balgownie, NSW 2519, Australia.
Belinda L CurtisYour Village Vet Balgownie, Balgownie, NSW 2519, Australia.
Lezanne OoiMolecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.ORCID 0000-0001-9241-8268
Ronald SluyterMolecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.ORCID 0000-0003-4909-686X

Funding

Australian Companion Animal Health Foundation 001/2016
6 · The paper itself

Abstract

Thrombosis is one of the most prevalent and serious health issues amongst humans. A key component of thrombotic events is the activation and aggregation of platelets, of which the P2Y

Indexed as

Blood PlateletsPlatelet AggregationReceptors, Purinergic P2Y1Receptors, Purinergic P2Y12Adenosine DiphosphateAnimalsCatsDogsHumansPurinergic P2Y Receptor AntagonistsAdenosine DiphosphatePurinergic P2Y Receptor AntagonistsReceptors, Purinergic P2Y1Receptors, Purinergic P2Y12ADPcatdoghaemostasisP2Y12 receptorP2Y1 receptorplateletpurinergic receptorpurinergic signallingstrokethrombosisveterinary medicine

Identifiers

PMID39940972
PMCPMC11818226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.